The Relationship between Natriuretic Peptide Precursor a Gene T2238C Polymorphism and Hypertension : A Meta-Analysis

Abstract EN

Single studies attempting to associate ANP gene T2238C (rs5065) polymorphism with hypertension have so far reported inconclusive results.

We therefore aimed to evaluate this association via a meta-analysis.

Data on 7 studies with a total of 4068 subjects were available and analyzed using the random-effects model with assessment of heterogeneity and publication bias.

Overall comparison of 2238C with 2238T yielded a 23% reduced, albeit nonsignificant, risk for hypertension (95% CI: 0.38–1.59; P=.485), while accompanying significant heterogeneity (I2=88.3%) and publication bias (P=.051).

Subgroup analysis by study design demonstrated opposite associations between population-based (OR=0.33; 95% CI: 0.13–0.80; P=.015) and hospital-based studies (OR=1.15; 95% CI: 0.79–1.68; P=.454).

Further meta-regression analysis exclusively indicated the significant influence of study design (P=.042) on heterogeneity.

Taken together, these findings support the notion that carriers of 2238C allele were at moderate decreased risk of developing hypertension, whereas study design was identified as a potentially significant source of between-study heterogeneity.